Persistent pleural effusion developed in an 81-year-old man with acute pulmonary edema due to myocardial dysfunction. Daily chest tube drainage was 1,000 to 1,400 mL. Despite total parenteral nutrition and albumin supplementation, drainage did not decrease. However, continuous infusion of a somatostatin analog was effective in controlling the effusion.
Get full access to this article
View all access options for this article.
References
1.
NishiHNakaharaMOginoNNakaoKLeeCMTsujimatoM. A case of chylothorax following resection of esophageal carcinoma — successful treatment by pleurodesis with OK-432 and minocycline. Jpn J Gastroenterol Surg1999; 32: 1203–7.
2.
KogaYMitaYDobashiKMasuoTAiharaMShimizuYLung cancer with chylothorax successfully treated by chemical pleurodesis with OK-432 [Japanese]. Nihon Kokyuki Gakkai Zasshi1999; 37: 627–30.
3.
RimensbergerPCMüller-SchenkerBKalangosABeghettiM. Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg1998; 66: 253–4.
4.
KellyRFShumwaySJ. Conservative management of postoperative chylothorax using somatostatin. Ann Thorac Surg2000; 69: 1944–5.
5.
BuettikerVHugMIBurgerRBaenzigerO. Somatostatin: a new therapeutic option for the treatment of chylothorax. Intensive Care Med2001; 27: 1083–6.
6.
JohnsonJL. Pleural effusions in cardiovascular disease. Pearls for correlating the evidence with the cause. Postgrad Med2000; 107: 95–101.
7.
MarkhamKMGloverJLWelshRJLucasRJBendickPJ. Octreotide in the treatment of thoracic duct injuries. Am Surg2000; 66: 1165–7.
